CME Outfitters Announces Live neuroscienceCME TV Broadcast: "Augmenting Antidepressants with Atypical Antipsychotics in Major Depressive Disorder" Premieres Wednesday, June 11, 2008

Share Article

CME Outfitters announces an upcoming live and interactive neuroscienceCME TV activity titled "Augmenting Antidepressants with Atypical Antipsychotics in Major Depressive Disorder." Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, June 11, 2008, from 12:00 p.m.-1:00 p.m. ET, the activity will describe the neurobiology of depression as it relates to mechanisms of drug action, and discuss augmentation strategies with atypical antipsychotics for the substantial group of patients who do not remit with traditional antidepressants.

CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based neuroscienceCME TV activity titled "Augmenting Antidepressants with Atypical Antipsychotics in Major Depressive Disorder."

Premiering Wednesday, June 11, 2008, from 12:00 p.m.-1:00 p.m. ET, the activity will describe the neurobiology of depression as it relates to mechanisms of drug action, and discuss augmentation strategies with atypical antipsychotics for the substantial group of patients who do not remit with traditional antidepressants. The recorded satellite broadcast will re-air from 3:00 p.m.-4:00 p.m. ET. This CE activity will also be available as an archived webcast, podcast, and telephone audioconference shortly after the broadcast premiere.

CME Outfitters, LLC, gratefully acknowledges the contributions of CME LLC as its co-sponsor for this continuing education activity.

There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:

Statement of Need:
Major depressive disorder (MDD) is a debilitating illness that affects 13% of the U.S. population. Antidepressant (AD) medications, including SSRIs, SNRIs, tricyclic antidepressants, and novel agents such as bupropion, have been the mainstay of treatment. Data from the NIMH-sponsored Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial showed that only one-third of those with MDD achieved remission after initial treatment with an AD; an additional 25% remit after switching to another AD. These findings underscore the need for alternative treatment strategies for patients who do not remit with ADs alone.

Atypical antipsychotics can be effective adjunct medications for the treatment of MDD. These agents have an array of pharmacodynamic and pharmacokinetic properties that clinicians need to understand. Translating our understanding of the link between the neurobiology of depression and the differential responses seen among patients with traditional AD treatment is critical to identifying optimal treatment strategies. In this case-based neuroscienceCME activity, faculty will discuss strategies for improving rates of remission, the neurobiological underpinnings of MDD, mechanisms of action of pharmacotherapies, and evidence-based augmentation strategies with atypical antipsychotics.

Moderator:
Charles B. Nemeroff, MD, PhD
Reunette W. Harris Professor and Chairman
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA

Faculty:
Mark Hyman Rapaport, MD
Chairman, Department of Psychiatry and Mental Health
Cedars-Sinai Medical Center
The Polier Endowed Chair in Schizophrenia and Related Disorders
Vice Chairman and Professor in Residence
David Geffen School of Medicine at UCLA
Los Angeles, CA

Andrew A. Nierenberg, MD
Associate Professor of Psychiatry
Harvard Medical School
Associate Director, Depression Clinical Research Program
Massachusetts General Hospital
Boston, MA

Learning Objectives:
At the end of this CE activity, participants should be able to:

  • Identify remission rates among patients treated for major depressive disorder and strategies to improve remission rates in depression.
  • Explain the neurobiology of depression and the mechanisms by which traditional antidepressants and atypical antipsychotic medications exert their effects.
  • Compare and contrast the efficacy and safety of atypical antipsychotics when used as augmentation to traditional antidepressants in the management of depression.

Target Audience:
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other clinicians interested in mental health.

Commercial Support:
CME Outfitters, LLC, and CME LLC gratefully acknowledge an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceuticals, Inc., in support of this CE activity.

Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned code 6WASUP-PRV-0636. 1.0 contact hours will be awarded upon successful completion. This activity is co-provided with CME LLC.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-999-08-012-L01-P (live presentation) 376-999-08-012-H01-P (recorded programs)

Post-tests, credit request forms, and activity evaluations can be completed online at http://www.neuroscienceCME.com (click on the Testing/Certification link under the Resources tab - requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.

About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences.

About neuroscienceCME TV:
Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference, neuroscienceCME TV is a one-hour, live and interactive continuing education (CE) activity where leading experts discuss clinically relevant, evidence-based issues facing mental health practitioners. Each broadcast's interactivity is enhanced by offering a Q&A segment during which the faculty presenters can respond to audience comments and questions posed via e-mail, fax, or phone. CME Outfitters has also developed a web-based instant polling feature that allows live webcast participants a chance to provide real-time input. Online CE credit is offered to participants upon completion of each activity, at neuroscienceCME.com.

To view all recent neuroscienceCME press releases, visit http://www.neuroscienceCME.com and click on "News Room" or visit http://www.prweb.com and search for "neuroscienceCME."

Clinical Compass, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on "Subscribe to Clinical Compass."

Contact: Jessica Primanzon
CME Outfitters, LLC
240.243.1308 direct
240.243.1033 fax

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jessica Primanzon
Visit website